Please assess the completion status of the following clinical trial:

Trial Title: Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Subjects must be males or females 18-85 years of age who currently smoke cigarettes daily and are willing to stop smoking~Exclusion Criteria:~History of cardiovascular disease, stomach ulcer or diabetes unless physician's written approval is obtained.~Use of other forms of tobacco/nicotine containing products other than cigarettes within 30 days before baseline visit.~Use of nicotine replacement therapies or other smoking cessation medicines/non-drug therapies within 30 days before the baseline visit.~Pregnancy or intending to become pregnant.~Hypersensitivity to the product, history of alcohol or substance abuse.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Nicotine (Type: EXPERIMENTAL): Nicotine Spray
- Placebo (Type: PLACEBO_COMPARATOR): Placebo to match Nicotine spray

Based on this trial design, predict the completion outcome and termination type (if applicable).